Target intelligence / Profile preview

Chronically Activated Lymphocyte

Molecular classification
Immune Cell, Lymphocyte, T cell, B cell
01

Overview

A chronically activated lymphocyte is a lymphocyte that remains in an activated state for a prolonged period due to persistent antigen exposure, dysregulation of signaling pathways, or other factors. This chronic activation can lead to altered function, exhaustion, apoptosis resistance, or pathological proliferation, contributing to diseases such as chronic infections, autoimmune disorders, and hematologic malignancies. Targeting these cells is important for therapeutic intervention in these diseases.

Other names
Persistent Activated LymphocyteChronically Stimulated Lymphocyte
02

Mechanism of action

Varies depending on the specific drug and underlying cause of chronic activation; examples include blocking signaling pathways (e.g., NF-kB), inducing apoptosis, inhibiting cell proliferation, or modulating immune checkpoints.

03

Biological functions

Immune responseAdaptive immunityCytokine productionAntigen presentationCell proliferationCell deathSignal transductionAntibody production
04

Disease associations

Chronic infectionAutoimmune diseaseHematologic malignancyChronic lymphocytic leukemia (CLL)Inflammation
05

Safety considerations

Increased risk of infectionAutoimmunityCytokine release syndromeOff-target effects of immunomodulatory therapiesDevelopment of resistance to therapy
06

Interacting drugs

Immunosuppressants

4 more in the full profile.

07

Biomarkers

CD69CD25 (IL-2 receptor α chain)HLA-DRPD-1CTLA4Cytokine profiles (e.g., IL-2, IFN-γ, IL-10)NF-kB activityIGHV mutation status (in CLL)

Beyond the preview

Go deeper on Chronically Activated Lymphocyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chronically Activated Lymphocyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call